Improving metabolic health in African American pregnant women
A Randomized Control Trial to improve metabolic outcomes in African American pregnant women
This study is looking at how improving sleep can help pregnant African American women with gestational diabetes manage their blood sugar better, so they can feel healthier and support their babies' health too.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Illinois at Chicago NIH-funded |
| Lab location | 1 site (Chicago, UNITED STATES) |
| Project ID | NIH-11082990 on NIH RePORTER |
What this research studies
This research focuses on addressing maternal hyperglycemia, particularly Gestational Diabetes Mellitus (GDM), which affects a significant number of African American pregnant women. The study aims to implement a nonpharmacologic sleep intervention designed to enhance sleep quality and duration, which may help improve glucose metabolism. By utilizing a behavioral approach that incorporates sleep hygiene principles, the research seeks to identify modifiable risk factors that can lead to better metabolic outcomes for both mothers and their offspring. Participants will engage in lifestyle modifications that target their sleep patterns and overall health.
Who could benefit from this research
Good fit: Ideal candidates for this research are African American pregnant women who are at risk for or diagnosed with Gestational Diabetes Mellitus.
Not a fit: Patients who are not African American or who are not currently pregnant may not receive benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved metabolic health outcomes for African American pregnant women, reducing the risks associated with GDM and its long-term effects.
How similar studies have performed: Previous research has shown that cognitive and behavioral methods can effectively improve sleep quality, suggesting potential for success in this novel approach.
Where this research is happening
Chicago, UNITED STATES
- University of Illinois at Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Izci Balserak, Bilgay — University of Illinois at Chicago
- Study coordinator: Izci Balserak, Bilgay
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.